Originally posted by kulandaisamy
View Post
-
I do not think they got an error. When I run the code I get back the qcovs value and its a number value. I think that they are asking for the hsp_middleline value that shows where the protein and matches and doesn't. The only way I know how to get that is in the xml format and then you either have to cut and paste it from there or have a scritp to extract it from the file. Which is out of m relm of ability, Maybe GenoMax knows how to do that from the standalone BLAST but I have not done it before, other then just using the xml format option.Leave a comment:
-
You are running blast+. Not the latest (v. 2.2.30) but close enough. Use @skbrimer's suggestion for the command above.Leave a comment:
-
blastp: 2.2.28+
Package: blast 2.2.28, build Jun 3 2013 11:32:37Leave a comment:
-
I'm not sure how you would run the search in the older version of BLAST, NCBI recommends you download the new BLAST+ here is a link to a discussion https://www.biostars.org/p/9480/Originally posted by kulandaisamy View Post
I have only used the newer version so the line of code would look something like....
blastp -db nr -query plas_3d7.fasta -query_loc approved_target.fasta -out blas.tab -outfmt "6 qgi sgi qcovs" -remote
Or something to this effect, I'm not sure what the -d flag is on the blastall version of blast but hopefully this can get you pointed in the right direction.Leave a comment:
-
blastall -p blastp -i plas_3d7.fasta -d approved_target.fasta -m 8 > blas.tab
my output file contaiing only Query id, Subject id, % identity, alignment length, mismatches, gap openings, q. start, q. end, s. start, s. end, e-value, bit score.
i want query coverage resultsLeave a comment:
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Leave a comment: